A carnosine intervention study in overweight human volunteers: Bioavailability and reactive carbonyl species sequestering effect

Barbora De Courten, Luca Regazzoni, Davide Garzon, Alessandra Altomare, Cristina Marinello, Michaela Jakubova, Silvia Vallova, Patrik Krumpolec, Marina Carini, Jozef Ukropec, Barbara Ukropcova, Giancarlo Aldini

Research output: Contribution to journalArticleResearchpeer-review

28 Citations (Scopus)


Carnosine is a natural dipeptide able to react with reactive carbonyl species, which have been recently associated with the onset and progression of several human diseases. Herein, we report an intervention study in overweight individuals. Carnosine (2 g/day) was orally administered for twelve weeks in order to evaluate its bioavailability and metabolic fate. Two carnosine adducts were detected in the urine samples of all subjects. Such adducts are generated from a reaction with acrolein, which is one of the most toxic and reactive compounds among reactive carbonyl species. However, neither carnosine nor adducts have been detected in plasma. Urinary excretion of adducts and carnosine showed a positive correlation although a high variability of individual response to carnosine supplementation was observed. Interestingly, treated subjects showed a significant decrease in the percentage of excreted adducts in reduced form, accompanied by a significant increase of the urinary excretion of both carnosine and carnosine-acrolein adducts. Altogether, data suggest that acrolein is entrapped in vivo by carnosine although the response to its supplementation is possibly influenced by individual diversities in terms of carnosine dietary intake, metabolism and basal production of reactive carbonyl species.

Original languageEnglish
Article number27224
JournalScientific Reports
Publication statusPublished - 6 Jun 2016

Cite this